Compare Equitable Holdings Inc. Common Stock (EQH) vs Cassava Sciences Inc (FLNA) Price & Performance

Equitable Holdings (EQH) trades at $53.12, down 0.75% on the day, with strong analyst support (95% buy ratings) and a $64.71 consensus price target suggesting 22% upside. Recent quarterly earnings have consistently beaten expectations, though the company reported a net loss of $1.38B for 2025. The planned merger with Corebridge and expansion into fee-based businesses are key growth drivers, while high debt-to-asset ratio of 2.07 presents financial risk.

EQH shows mixed fundamentals with positive earnings momentum but negative profitability metrics. The stock offers significant upside potential based on analyst targets, supported by strategic initiatives and dividend appeal. Key risks include execution of the Corebridge merger, persistent net losses, and high leverage. Investors should weigh strong analyst conviction against fundamental weaknesses.

FLNA trades at $0.7434, down 3.39% today, with a bearish technical signal despite recent positive FDA news lifting a clinical hold on its epilepsy drug. The company shows improving quarterly EPS beats but remains unprofitable with negative cash flows. Analyst consensus is strongly bullish with 8 buy ratings versus 4 holds.

The outlook hinges on clinical progress—FDA clearance enables Phase 2a trials in 2027, a key catalyst. Risks include sustained cash burn and fiduciary concerns highlighted in recent news. Investors should weigh the high analyst optimism against fundamental weaknesses and regulatory execution risks.